World's Best Scientists 2026 revealed!
Clinical and Experimental Pharmacology and Physiology
H-index 18

Clinical and Experimental Pharmacology and Physiology

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 2990 16 28 6

Additional Metrics

Number of Best Scientists*: 107
Documents by Best Scientists*: 126
Top 100 Ranked Scientists*: 3
SCIMAGO H-index: 118
SCIMAGO SJR: 0.625
Impact Factor: 2.5

Overview

Top Research Topics at Clinical and Experimental Pharmacology and Physiology?

The scientific interests tackled in the journal are Internal medicine, Endocrinology, Blood pressure, Pharmacology and Anesthesia. It explores research in Internal medicine and the adjacent study of Cardiology. The presentations discussing Endocrinology offer insights in topics such as Nitric oxide, Stimulation, Vasodilation, Diabetes mellitus and Excretion.

It is mostly focused on Nitric oxide, specifically Nitric oxide synthase. It connects the study in Blood pressure with the closely related area of Hemodynamics. Discussions in it are anchored in the subject of Pharmacology and the similar topic of Biochemistry.

Clinical and Experimental Pharmacology and Physiology features studies on Renin–angiotensin system, including topics such as Plasma renin activity. The research on Kidney discussed in the journal draws on the closely related field of Renal function.

  • Internal medicine (60.68%)
  • Endocrinology (52.39%)
  • Blood pressure (15.42%)

What are the most cited papers published in the journal?

  • MULTIPLE COMPARISON PROCEDURES UPDATED (499 citations)
  • Discovery of curcumin, a component of golden spice, and its miraculous biological activities (488 citations)
  • AGE-RELATED CHANGES IN THE STRUCTURE AND FUNCTION OF SKELETAL MUSCLES (471 citations)

Research areas of the most cited articles at Clinical and Experimental Pharmacology and Physiology:

The main points discussed in the journal papers deal with Internal medicine, Endocrinology, Blood pressure, Pharmacology and Biochemistry. Issues in Internal medicine were discussed in the journal articles, taking into consideration concepts from other disciplines like Diabetes mellitus and Cardiology. The studies tackled in the journal papers, which mainly focus on Endocrinology, apply to Receptor as well.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Gene
  • Enzyme

The previous edition focused in particular on these issues:

The foci of Clinical and Experimental Pharmacology and Physiology are Internal medicine, Endocrinology, Pharmacology, Oxidative stress and Cancer research. Internal medicine research presented in it encompasses a variety of subjects, including Diabetes mellitus, Gastroenterology and Cardiology. The Endocrinology study featured in Clinical and Experimental Pharmacology and Physiology draws connections with the study of Inflammation.

Studies on Pharmacology discussed in the journal link to the field of Receptor. The work on Oxidative stress tackled in the journal brings together disciplines like Reactive oxygen species and Antioxidant. Cancer research research in Clinical and Experimental Pharmacology and Physiology involves the investigation of Downregulation and upregulation studies, all of which are linked to disciplines such as Gene knockdown.

The most cited articles from the last journal are:

  • Colchicine treatment can improve outcomes of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. (21 citations)
  • Paracetamol - An old drug with new mechanisms of action. (13 citations)
  • Tenacissoside H promotes neurological recovery of cerebral ischaemia/reperfusion injury in mice by modulating inflammation and oxidative stress via TrkB pathway. (6 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Clinical and Experimental Pharmacology and Physiology (based on the number of publications) are:

  • Richard D. Gordon (68 papers) absent at the last edition,
  • Yukio Yamori (61 papers) absent at the last edition,
  • John P. Coghlan (60 papers) absent at the last edition,
  • Colin I. Johnston (58 papers) absent at the last edition,
  • Roger G. Evans (55 papers) published 2 papers at the last edition, 1 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Clinical and Experimental Pharmacology and Physiology (based on the number of publications) are:

  • University of Melbourne (535 papers) absent at the last edition,
  • Monash University (195 papers) published 5 papers at the last edition, 4 more than at the previous edition,
  • University of Queensland (156 papers) published 4 papers at the last edition, 1 less than at the previous edition,
  • University of Sydney (148 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Monash University, Clayton campus (124 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 6.77% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 7.82% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.70% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 13.41% of all publications and 72.07% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Clinical and Experimental Pharmacology and Physiology

Pursuing a career in the field of Clinical and Experimental Pharmacology and Physiology opens a wide range of opportunities. Professionals can engage in various roles such as clinical pharmacologists, research scientists, laboratory technicians, medical writers, and educators in both academia and industry. Opportunities are not limited to research and teaching, and broad career paths also encompass fields like health policy, patent law and consulting, precise medicine, and bioinformatics. Moreover, this profession enables individuals to make significant contributions to medical research, influencing public health policies, and developing innovative therapies for various diseases. A career in this field often requires strong problem-solving skills and analytical thinking, coupled with an ongoing pursuit of academic achievement via research and publications. Given the current digital era, more universities are offering online programs to help students achieve their academic goals, easing the geographical and time constraints typically associated with traditional degree programs. For individuals interested in pursuing this line of work, there are various online nursing programs in Pennsylvania that equip students with the necessary knowledge and skills to thrive in this fast-evolving field. After successfully completing a degree in Clinical and Experimental Pharmacology and Physiology, graduates are expected to have a comprehensive understanding of drug mechanisms and actions, disease pathophysiology, and the application of this knowledge in the development of new experimental therapeutics. As such, they are well-positioned to make significant contributions to the healthcare system, improving patient care and outcomes.

Top Publications

  • Targeting autophagy in neurodegenerative diseases: From molecular mechanisms to clinical therapeutics.

    Amir Ajoolabady;Hamid Aslkhodapasandhokmabad;Nils Henninger;Laurie J Demillard

    (2021)
    27 Citations
  • Vascular effects of a single bout of electronic cigarette use.

    Ramon Cossio;Zachary A Cerra;Hirofumi Tanaka

    (2020)
    20 Citations
  • Prognostic value of inflammatory and nutritional indexes among advanced NSCLC patients receiving PD‐1 inhibitor therapy

    (2022)
    15 Citations
  • Antibody-mediated neutralization of IL11 signalling reduces ERK activation and cardiac fibrosis in a mouse model of severe pressure overload.

    Wei‐Wen Lim;Wei‐Wen Lim;Ben Corden;Lei Ye;Sivakumar Viswanathan

    (2021)
    13 Citations
  • Simultaneous angiotensin receptor blockade and glucagon-like peptide-1 receptor activation ameliorate albuminuria in obese insulin-resistant rats.

    Ruben Rodriguez;Benny Escobedo;Andrew Y. Lee;Max Thorwald

    (2020)
    11 Citations
  • Intra-operative and early post-operative prediction of cardiac surgery-associated acute kidney injury: Urinary oxygen tension compared with plasma and urinary biomarkers.

    Khin M Noe;Jennifer P Ngo;Andrew Martin;Michael Z L Zhu

    (2021)
    10 Citations
  • Impact of Custodiol-N cardioplegia on acute kidney injury after cardiopulmonary bypass.

    Nina Feirer;Maja‐Theresa Dieterlen;Kristin Klaeske;Philipp Kiefer

    (2020)
    6 Citations
  • Increased lipoxygenase and decreased cytochrome P450s metabolites correlated with the incidence of diabetic nephropathy: Potential role of eicosanoids from metabolomics in type 2 diabetic patients.

    Liyuan Peng;Bei Sun;Yajin Liu;Jing Huang

    (2021)
    6 Citations
  • Amnion membranes support wound granulation in a delayed murine excisional wound model

    (2022)
    4 Citations
  • Angiotensin receptor blockade with olmesartan alleviates brain pathology in obese OLETF rats

    (2022)
    4 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their medical careers beyond traditional routes, several online degree options offer flexibility and specialized skills. Programs such as ultrasound tech online programs provide essential training in diagnostic imaging, preparing students for roles in hospitals and clinics without the need for on-site attendance.

Radiology also presents a viable path, with some of the best online radiology tech programs offering affordable associate degrees. These programs equip students with the knowledge to operate imaging equipment and assist in patient diagnosis.

For those focused on nutritional health, comprehensive education is available through top-ranked best dietetics programs. These master’s degrees prepare graduates for careers as registered dietitians, emphasizing clinical nutrition and public health.

Finally, aspiring healthcare support professionals can explore online medical assistant programs with financial aid, which combine flexible learning schedules with financial support options, helping students enter the healthcare workforce efficiently.

Best Scientists Contributing to This Journal